Delivery Order SPE2DR25D3201-SPE2DR26FT4BQ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,916.78 to AmerisourceBergen Drug Corp for PHESGO 600-600 mg pharmaceutical products (20,000 units of 10ml vials). This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The award was made on September 25, 2025, with an ultimate completion date of October 17, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of...
- The Defense Logistics Agency awarded a $21,833.56 firm fixed price delivery order to AmerisourceBergen Drug Corp for PHESGO 600-600 mg pharmaceutical products (20,000 units of 10ml vials), with an ultimate completion date of November 10, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $10,916.78 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of PHESGO 600-600 MG pharmaceutical product (20,000 units of 10ML vials) with an ultimate completion date of October 14, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The award was...
- The Defense Logistics Agency (DLA) awarded a $10,916.78 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of PHESGO 600-600 mg pharmaceutical product in 20,000 units of 10ml vials. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a non-competitive, non-set-aside award to support federal medical supply requirements. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $10,916.78 to AmerisourceBergen Drug Corp for PHESGO 600-600 MG pharmaceutical products, with an order quantity of 20,000 units in 10ML vials. The contract is a firm fixed price delivery order with no set-aside designation, awarded on September 2, 2025, with an ultimate completion date of September 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $5,458.39 delivery order to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 MG in 10ML vials. This delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, operates under a firm fixed-price contract type with no set-aside designation. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order valued at $5,458.39 to AmerisourceBergen Drug Corp for PHESGO 600-600 mg pharmaceutical products (20,000 units of 10ml vials). This firm fixed-price delivery order, issued on July 24, 2025, with completion targeted for August 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award utilized no set-aside designation and specifies performance at the...
- This delivery order, valued at $16,375.17, was awarded on August 21, 2025, to AmerisourceBergen Drug Corp for the supply of PHESGO 600-600 mg in 10 mL unit dosages totaling 20,000 units. The contract is a firm fixed price delivery order with an ultimate completion date of September 12, 2025, and was funded by the Defense Logistics Agency's Medical Supply Chain. The award was made on a competitive basis without any set-aside designation. AmerisourceBergen's place of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $5,458.39 to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 mg in 10ml vials, with a completion deadline of September 16, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $5,458.39 delivery order to AmerisourceBergen Drug Corp for PHESGO 600-600 mg pharmaceutical products totaling 20,000 units in 10ml formulations. This competitively awarded, firm fixed-price delivery order is expected to be completed by August 21, 2025, with performance based at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT4BQDelivery Order
The Defense Logistics Agency awarded a $23,009.20 delivery order to AmerisourceBergen Drug Corp for PHESGO 600-600 MG pharmaceutical products (20,000 units of 10ML vials). This is a firm fixed price, non-competitive delivery order with an ultimate completion date of December 9, 2025, to be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for the company's comprehensive pharmaceutical supply support to military healthcare systems. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and established federal vendor that supplies brand-name medications, generic drugs, vaccines, and specialized medical commodities to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. This delivery order for PHESGO, an oncology treatment, reflects the company's role as a critical supplier within the DLA's medical supply chain and demonstrates its capacity to fulfill federal pharmaceutical procurement requirements through competitively awarded contracts. The company's extensive portfolio of federal awards and substantial prime indefinite delivery vehicle position AmerisourceBergen as a preferred source for military medical supply needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.0k | 11/17/25 |